eXoZymes, Inc. (EXOZ)
4.30
+0.19
(+4.62%)
USD |
NASDAQ |
Nov 06, 10:07
eXoZymes Debt to Equity Ratio : 0.2969 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2969 |
| March 31, 2026 | 0.7623 |
| December 31, 2025 | 0.3659 |
| September 30, 2025 | 0.2456 |
| June 30, 2025 | 0.1927 |
| March 31, 2025 | 0.1493 |
| Date | Value |
|---|---|
| December 31, 2024 | 0.1331 |
| September 30, 2024 | -1.421 |
| June 30, 2024 | |
| December 31, 2023 | -4.194 |
| December 31, 2022 | 0.4436 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Anika Therapeutics, Inc. | 0.1839 |
| Perspective Therapeutics, Inc. | 0.0122 |
| MiMedx Group, Inc. | 0.00 |
| ABVC BioPharma, Inc. | 0.2807 |
| Endonovo Therapeutics, Inc. | -0.2343 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.982M |
| Total Liabilities (Quarterly) | 4.328M |
| Shareholders Equity (Quarterly) | 3.654M |
| Current Ratio | 3.813 |
| Net Debt Paydown Yield | 0.06% |